IDO1 and melanoma: Notably, TRP depletion and KYN production may be promoted by SLN IDO1+ DC subsets, including pDCs, dDCs and LCs, leading to effector T cells impairment, enhancing Tregs, sustaining a tolerogenic microenvironment, promoting SLN melanoma metastases.